Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F9AP4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,983
Award facts
- Contract value 100% obligated
- $21,982.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,982.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GARDASIL 9 vaccine syringes (0.5ML) on November 6, 2025, with completion scheduled for November 7, 2025. The award was made without a set-aside designation through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The GARDASIL 9 vaccine delivery supports the Defense Health Agency and broader military healthcare systems' immunization programs. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its established capability as a critical vendor for pharmaceutical procurement, with consistent experience delivering vaccines, specialty medications, and medical supplies through firm fixed-price delivery orders across multiple therapeutic domains. The DLA's ongoing modernization of its pharmaceutical procurement through the Pharmaceutical Prime Vendor Global Program Generation V initiative reflects the strategic importance of reliable vaccine supply chains to military medical readiness and personnel health protection.
Quick answers
Who was awarded contract SPE2DR26F9AP4?
SPE2DR26F9AP4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26F9AP4 worth?
The government has obligated $21,983 on SPE2DR26F9AP4.
Is contract SPE2DR26F9AP4 an order under another contract?
Yes. SPE2DR26F9AP4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AP4 competed?
The extent of competition for SPE2DR26F9AP4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award